s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Friday, April 11, 2014
Accession number
0001019687-14-001345
Documents
FINAL PROSPECTUS
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header